Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Cannabidiol (CBD) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Food Grade Market Performance (Volume)
2.1.2 Pharmaceutical Grade Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Food Grade Market Performance (Value)
2.2.2 Pharmaceutical Grade Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Anxiety Market Performance (Volume)
3.1.2 Fibromyalgia (FM) Market Performance (Volume)
3.1.3 Diabetes Market Performance (Volume)
3.1.4 Other Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 ENDOCA
4.1.1 ENDOCA Profiles
4.1.2 ENDOCA Product Information
4.1.3 ENDOCA Cannabidiol (CBD) Business Performance
4.1.4 ENDOCA Cannabidiol (CBD) Business Development and Market Status
4.2 CBD American Shaman
4.2.1 CBD American Shaman Profiles
4.2.2 CBD American Shaman Product Information
4.2.3 CBD American Shaman Cannabidiol (CBD) Business Performance
4.2.4 CBD American Shaman Cannabidiol (CBD) Business Development and Market Status
4.3 Gaia Botanicals
4.3.1 Gaia Botanicals Profiles
4.3.2 Gaia Botanicals Product Information
4.3.3 Gaia Botanicals Cannabidiol (CBD) Business Performance
4.3.4 Gaia Botanicals Cannabidiol (CBD) Business Development and Market Status
4.4 Isodiol
4.4.1 Isodiol Profiles
4.4.2 Isodiol Product Information
4.4.3 Isodiol Cannabidiol (CBD) Business Performance
4.4.4 Isodiol Cannabidiol (CBD) Business Development and Market Status
4.5 Medical Marijuana
4.5.1 Medical Marijuana Profiles
4.5.2 Medical Marijuana Product Information
4.5.3 Medical Marijuana Cannabidiol (CBD) Business Performance
4.5.4 Medical Marijuana Cannabidiol (CBD) Business Development and Market Status
4.6 Aurora Cannabis (AC)
4.6.1 Aurora Cannabis (AC) Profiles
4.6.2 Aurora Cannabis (AC) Product Information
4.6.3 Aurora Cannabis (AC) Cannabidiol (CBD) Business Performance
4.6.4 Aurora Cannabis (AC) Cannabidiol (CBD) Business Development and Market Status
4.7 Cannoid
4.7.1 Cannoid Profiles
4.7.2 Cannoid Product Information
4.7.3 Cannoid Cannabidiol (CBD) Business Performance
4.7.4 Cannoid Cannabidiol (CBD) Business Development and Market Status
4.8 Canopy Growth Corporation
4.8.1 Canopy Growth Corporation Profiles
4.8.2 Canopy Growth Corporation Product Information
4.8.3 Canopy Growth Corporation Cannabidiol (CBD) Business Performance
4.8.4 Canopy Growth Corporation Cannabidiol (CBD) Business Development and Market Status
4.9 CV Sciences
4.9.1 CV Sciences Profiles
4.9.2 CV Sciences Product Information
4.9.3 CV Sciences Cannabidiol (CBD) Business Performance
4.9.4 CV Sciences Cannabidiol (CBD) Business Development and Market Status
4.10 IRIE CBD
4.10.1 IRIE CBD Profiles
4.10.2 IRIE CBD Product Information
4.10.3 IRIE CBD Cannabidiol (CBD) Business Performance
4.10.4 IRIE CBD Cannabidiol (CBD) Business Development and Market Status
4.11 Elixinol
4.12 NuLeaf Naturals
4.13 PharmaHemp
4.14 Folium Biosciences
5 Market Performance for Manufacturers
5.1 Asia-Pacific Cannabidiol (CBD) Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Asia-Pacific Cannabidiol (CBD) Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Asia-Pacific Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
5.4 Asia-Pacific Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 Japan Market Performance for Manufacturers
6.2.1 Japan Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 Japan Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 Japan Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 Japan Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 South Korea Market Performance for Manufacturers
6.3.1 South Korea Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 South Korea Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 South Korea Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 South Korea Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 India Market Performance for Manufacturers
6.4.1 India Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 India Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 India Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 India Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Southeast Asia Market Performance for Manufacturers
6.5.1 Southeast Asia Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Southeast Asia Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Southeast Asia Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Southeast Asia Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Australia Market Performance for Manufacturers
6.6.1 Australia Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Australia Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Australia Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Australia Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Market Performance for Manufacturers
6.7.1 Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Cannabidiol (CBD) Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Cannabidiol (CBD) Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Cannabidiol (CBD) Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Cannabidiol (CBD) Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Asia-Pacific Cannabidiol (CBD) Market Performance (Sales)
7.1 Asia-Pacific Cannabidiol (CBD) Sales (K Units) and Market Share by Regions 2014-2020
7.2 Asia-Pacific Cannabidiol (CBD) Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Asia-Pacific Cannabidiol (CBD) Price (USD/Unit) by Regions 2014-2020
7.4 Asia-Pacific Cannabidiol (CBD) Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales)
8.1 Asia-Pacific Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 China Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 Japan Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate 2014-2020
8.4 South Korea Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 India Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Southeast Asia Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 Australia Cannabidiol (CBD) Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Anxiety Industry
11.2 Fibromyalgia (FM) Industry
11.3 Diabetes Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Asia-Pacific Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Asia-Pacific Cannabidiol (CBD) Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 Japan Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 South Korea Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 India Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Southeast Asia Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Australia Cannabidiol (CBD) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Food Grade Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Pharmaceutical Grade Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales and Growth Rate Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Anxiety
12.3.3 Fibromyalgia (FM)
12.3.4 Diabetes
12.3.5 Other
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Asia-Pacific Cannabidiol (CBD) Price (USD/Unit) Trend 2021-2026
12.4.2 Asia-Pacific Cannabidiol (CBD) Gross Profit Trend 2021-2026
13 Conclusion